Harbor Osmosis國際資源效率主動型ETF EFFI 深 滬
交易中 05-18 11:40:12 美东时间
24.7248
0.000
0.00%
華盛通- 最 高0.00
- 今 開24.7248
- 成交量 18股
- 最 低 0.00
- 昨 收 24.7248
- 總市值 1.40亿
- 52周最高 25.5079
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 20.933
- 委 比 -99.67%
- 總股本 565.00万
- 歷史最高 25.5079
- 量 比 0.17
- 振 幅 0.00%
- 歷史最低 17.0723
- 每 手 1
- 風險率 1.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BTCS Q1 revenue rises 27% as DeFi operations expand
BTCS Q1 revenue rises 27% as DeFi operations expand Overview US blockchain infrastructure and DeFi operator's Q1 revenue rose 27% yr/yr, driven by Imperium Gross profit margin improved to 47% as business shifted to higher-margin DeFi operations Net loss widened to $69.1 mln, mainly due to realized a
05-15 20:41
ProFrac Q1 revenue rises sequentially, net loss narrows
ProFrac Q1 revenue rises sequentially, net loss narrows Overview U.S. energy services firm's Q1 revenue rose sequentially but fell short of year-ago levels Company posted Q1 net loss of $81 mln, narrower than prior quarter's loss Q1 results impacted by weather disruptions; operator activity improved
05-07 17:24
Amusement park operator Six Flags' Q1 revenue rises 12%, beats estimates
Amusement park operator Six Flags' Q1 revenue rises 12%, beats estimates Overview US amusement park operator's Q1 revenue rose 12% yr/yr, beating analyst expectations Adjusted EBITDA loss for Q1 narrowed and beat analyst expectations Company cites higher attendance and increased guest spending as ke
05-07 17:08
BRIEF-Saudi Aramco, Solutions by STC Collaborate To Deploy Next-Generation Supercomputer
BRIEF-Saudi Aramco, Solutions by STC Collaborate To Deploy Next-Generation Supercomputer May 6 (Reuters) - Saudi Arabian Oil Co 2222.SE : SAUDI ARAMCO - ARAMCO AND SOLUTIONS BY STC COLLABORATE TO DEPLOY NEXT-GENERATION SUPERCOMPUTER, POWERING UPSTREAM DIGITAL EXCELLENCE SAUDI ARAMCO - COLLABORATION
05-06 19:01
Estee Lauder Q3 EPS beats; ups FY view; raises job cut plan to up to 10,000
Estee Lauder Q3 EPS beats; ups FY view; raises job cut plan to up to 10,000 Overview Beauty products maker's fiscal Q3 net sales slightly beat analyst expectations, up 5% yr/yr Adjusted EPS for fiscal Q3 beat consensus, rising 40% yr/yr Company expands restructuring plan to 9,000-10,000 job cuts, vs
05-01 18:14
BRIEF-Kerry Group Q1 reported revenue -7.3% on currency effect, retains constant currency FY outlook
BRIEF-Kerry Group Q1 reported revenue -7.3% on currency effect, retains constant currency FY outlook April 30 (Reuters) - Kerry Group PLC KYGa.I : KERRY GROUP - Q1 VOLUME GROWTH OF 3.1%, A STRONG MARKET OUTPERFORMANCE THANKS TO SHARE GAINS IN AMERICAS, VOLUME GROWTH ACROSS ALL THREE REGIONS KERRY GR
04-30 14:01
BRIEF-Sk Hynix HBM Demand From Customers Over The Next Three Years Far Exceeds Co's HBM Production Capacity
BRIEF-Sk Hynix HBM Demand From Customers Over The Next Three Years Far Exceeds Co's HBM Production Capacity April 23 (Reuters) - SK Hynix Inc 000660.KS : SK HYNIX: DRAM SPOT MARKET DOES NOT REFLECT ENTIRE MEMORY MARKET SK HYNIX: UPWARD MEMORY PRICING CYCLE COULD LAST LONGER THAN IN THE PAST SK HYNIX
04-23 09:10
LIVE MARKETS-US stocks rise as investors choose optimism regarding Iran
LIVE MARKETS-US stocks rise as investors choose optimism regarding Iran US equity indexes rise with Nasdaq out front, up >1% Tech leads S&P 500 sector gainers; Real Estate sole loser Euro STOXX 600 index off ~0.2% Dollar ~flat; gold gains; U.S. crude up >1%; bitcoin up >4% U.S. 10-year Treasury yiel
04-22 22:44
BRIEF-Anthropic Acquires Startup Coefficient Bio For About $400 Million - The Information
BRIEF-Anthropic Acquires Startup Coefficient Bio For About $400 Million - The Information April 2 (Reuters) - ANTHROPIC ACQUIRES STARTUP COEFFICIENT BIO FOR ABOUT $400 MILLION - THE INFORMATION Source text: https://tinyurl.com/27eplaeo Further company coverage: [ ] (( Reuters.Briefs@thomsonreuters.c
04-03 08:09
BRIEF-Rademikibart Demonstrates Best-In-Class Potential In Phase 3 Atopic Dermatitis Study
BRIEF-Rademikibart Demonstrates Best-In-Class Potential In Phase 3 Atopic Dermatitis Study March 30 (Reuters) - Connect Biopharma Holdings Ltd CNTB.O : RADEMIKIBART DEMONSTRATES BEST-IN-CLASS POTENTIAL IN PHASE 3 ATOPIC DERMATITIS STUDY CONNECT BIOPHARMA HOLDINGS LTD - RADEMIKIBART ACHIEVES RAPID, D
03-30 21:20
